1 Centre for Rehabilitation Research, Department of Public Health, Aarhus University, Aarhus C, Denmark.
2 Sano Aarhus, Aarhus, Denmark.
Clin Rehabil. 2018 Nov;32(11):1431-1439. doi: 10.1177/0269215518780953. Epub 2018 Jun 8.
: To justify and describe an integrated rehabilitation programme for patients with chronic low back pain prior to evaluation in a randomized controlled trial.
: The Template for Intervention Description and Replication (TIDieR) checklist was used as a structural framework for the description of the integrated rehabilitation programme. As a part of the description, the Medical Research Council guidance, 'Developing and evaluating complex interventions', was used as a framework to justify the integrated rehabilitation programme.
: The integrated rehabilitation programme adopts a participatory biopsychosocial approach integrating inpatient activities supported by a multidisciplinary team and learning located within the patient's own environment. The integrated rehabilitation programme comprises 3 weeks of inpatient stay and 11 weeks of home-based activities. The inpatient part of the programme consists of 38 clinical activities, some of them delivered more than once. The 38 clinical activities were described in an activity sheet developed for this purpose, combining five items from the TIDieR.
: An integrated rehabilitation programme for patients with chronic low back pain has been justified and described. The intervention description is currently being used for successful structuring and standardization of the content and delivery of the integrated rehabilitation programme in a randomized controlled trial.
: ClinicalTrials.gov: NCT02884466.
在随机对照试验评估之前,为慢性下腰痛患者的综合康复计划提供依据并进行描述。
采用干预描述与复制模板(TIDieR)清单作为综合康复计划描述的结构框架。作为描述的一部分,采用医学研究委员会的“制定和评估复杂干预措施”指南作为框架,为综合康复计划提供依据。
综合康复计划采用参与式的身心社会方法,整合了多学科团队支持的住院活动和以患者自身环境为基础的学习。综合康复计划包括 3 周的住院治疗和 11 周的家庭活动。该计划的住院部分包括 38 项临床活动,其中一些活动不止进行一次。38 项临床活动在为此目的开发的活动表中进行了描述,该活动表结合了 TIDieR 的五个项目。
为慢性下腰痛患者制定并描述了综合康复计划。目前正在使用干预描述成功地对综合康复计划的内容和实施进行结构化和标准化,该计划正在进行一项随机对照试验。
ClinicalTrials.gov:NCT02884466。